This form typically offers better bioavailability than standard capsules
GLP-1 is a superstar hormone
The goal is to find the lowest dose that allows you to see results while minimizing side effects
03 Mindfulness, without the woo
Before starting Mounjaro , patients should discuss: Current Crohn's disease activity and recent flare history Existing gastrointestinal symptoms and their severity Nutritional status and any history of malabsorption All current medications, including immunosuppressants and biologics Previous complications such as strictures, fistulae, or surgeries Pregnancy intentions or breastfeeding status (tirzepatide is not recommended during pregnancy or breastfeeding) Seek urgent medical advice if you experience: Severe or persistent abdominal pain , particularly if different from usual Crohn's symptoms Severe, persistent abdominal pain radiating to the back stop tirzepatide immediately (possible pancreatitis) Bloody diarrhoea or significant increase in stool frequency Persistent vomiting preventing adequate fluid or medication intake Signs of dehydration : reduced urination, dizziness, confusion, or extreme thirst Symptoms suggesting bowel obstruction : severe cramping pain, abdominal distension, inability to pass stool or wind Unexplained fever or signs of infection Signs of severe allergic reaction (e.g., swelling of face/lips/tongue, breathing difficulty) call emergency services Symptoms of hypoglycaemia (if taking insulin or sulfonylureas): sweating, shakiness, confusion, irritability Routine monitoring should include regular assessment of: Weight trends and nutritional parameters Gastrointestinal symptom patterns Inflammatory markers (CRP, faecal calprotectin) as clinically indicated Blood glucose levels (if diabetic) Medication adherence and tolerability Renal function if experiencing significant gastrointestinal side effects Patients should never stop Crohn's disease medications without consulting their gastroenterology team, even if experiencing side effects from Mounjaro
10.1080/14728222.2017.1350264 Expert Opin
